IC's boomerang: everything old is new again

Make room for more sterile environments.

Nursing management·2004

Evolving infection control standards challenge compliance.

Nursing management·2003

Infection control risks "engineered out". Engineering controls foster better hand hygiene, aseptic techniques, and management of invasive devices.

Nursing management·2002

Practice analysis for infection control and epidemiology in the new millennium.

American journal of infection control·2002

Nursing work environment as a determinant of health care outcomes: A scoping review.

Nursing management·2026

Your story, your brand: A career core competency for nurses.

Nursing management·2026

Communication crossroads: Exploring generational dynamics in nursing from the bedside to the boardroom.

Nursing management·2026

Workplace Safety Champions: Strengthening safety culture through nurse engagement.

Nursing management·2026

Associations between the Pathway to Excellence® framework and nurse, patient, and organizational outcomes: A systematic review.

Nursing management·2026

Inspiring a culture of ownership through mutual accountability: A health care system's approach to connecting bedside expertise with boardroom strategy.

Nursing management·2026

Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy.

Research and practice in thrombosis and haemostasis·2026

Dose-response relationship of pre-ICU corticosteroids and influenza-associated pulmonary aspergillosis: a multicenter target trial emulation.

Annals of intensive care·2026

Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses.

Molecular therapy. Oncology·2026

SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity.

Journal of translational autoimmunity·2026

Multi-target Therapy with Rituximab plus Mycophenolate Mofetil versus Rituximab Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease.

The Journal of rheumatology·2026

Upadacitinib effectively suppresses IL13RA2 expression in primary human intestinal fibroblasts derived from Crohn's disease tissue.

Biochemical pharmacology·2026

Related Experiment Videos

IC's boomerang: everything old is new again

Related Concept Videos

Make room for more sterile environments.

Evolving infection control standards challenge compliance.

Infection control risks "engineered out". Engineering controls foster better hand hygiene, aseptic techniques, and management of invasive devices.

Practice analysis for infection control and epidemiology in the new millennium.

Nursing work environment as a determinant of health care outcomes: A scoping review.

Your story, your brand: A career core competency for nurses.

Communication crossroads: Exploring generational dynamics in nursing from the bedside to the boardroom.

Workplace Safety Champions: Strengthening safety culture through nurse engagement.

Associations between the Pathway to Excellence® framework and nurse, patient, and organizational outcomes: A systematic review.

Inspiring a culture of ownership through mutual accountability: A health care system's approach to connecting bedside expertise with boardroom strategy.

Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy.

Dose-response relationship of pre-ICU corticosteroids and influenza-associated pulmonary aspergillosis: a multicenter target trial emulation.

Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses.

SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity.

Multi-target Therapy with Rituximab plus Mycophenolate Mofetil versus Rituximab Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease.

Upadacitinib effectively suppresses IL13RA2 expression in primary human intestinal fibroblasts derived from Crohn's disease tissue.

Related Experiment Videos

IC's boomerang: everything old is new again

Abstract:

Related Concept Videos

Related Articles